Hoynoza

Biotechnology and medical science innovations in India.

About Hoynoza

Hoynoza is a Healthcare company. Biotechnology and medical science innovations in India. The company has 1 employees. Hoynoza offers products and services including Biosimilar Development and Cell and Gene Therapy. Its focus areas include Research and Development, Gene Therapy, Exosome Isolation and Biotechnology. Its legal entity in India is Hoynoza Pvt Ltd (U24290KA2022PTC166759).

Company details

Innovations in biotechnology and medical science are led by Hoynoza, where new ideas are blended with care to navigate healthcare transformation across various disciplines. Groundbreaking solutions in biosimilar development, cell and gene therapy, exosomes, and bio-organoids are undertaken, focusing on patient-centric approaches. Services for biopharmaceutical companies and research institutions are provided, ensuring quality and ethical advancements in monoclonal antibodies and diagnostic kits. A future where healthcare is revolutionized is envisioned by Hoynoza, with expertise in plasmid and organoid technologies.

  • Employees 1
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website hoynoza.com
  • Legal Name Hoynoza Pvt Ltd
  • Date of Incorporation 04 Oct, 2022
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Employee Count
    1

Products & Services of Hoynoza

Hoynoza offers a comprehensive portfolio of products and services, including Biosimilar Development and Cell and Gene Therapy.

Biosimilar Development
Biotechnology Services

Biosimilar development is conducted by Hoynoza for transformative healthcare solutions.

Cell and Gene Therapy
Therapeutic Innovations

Cell and gene therapy, including stem cell and viral vector technologies, are pioneered by Hoynoza for medical applications.

Board of directors of Hoynoza Private Limited (Hoynoza)

Hoynoza Private Limited is the primary company behind Hoynoza. The board of Hoynoza Private Limited currently have 4 directors; the longest-serving is Madhava Reddy Gongati, appointed in 2022.

DirectorDesignationAppointedTenureEntity
Madhava Reddy Gongati
DIN 09178841
Director04 Oct 20224 yrs 1 moHoynoza Private Limited
Srinivedha Krishnan
DIN 09756560
Director04 Oct 20224 yrs 1 moHoynoza Private Limited
Sathyabalan Murugesan
DIN 08603805
Director04 Oct 20224 yrs 1 moHoynoza Private Limited
Shougandh Ghosh
DIN 08828156
Director04 Oct 20224 yrs 1 moHoynoza Private Limited
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Hoynoza

Hoynoza has 1 employees.

Innovations in biotechnology and medical science are led by Hoynoza, where new ideas are blended with care to navigate healthcare transformation across various disciplines. Groundbreaking solutions in biosimilar development, cell and gene therapy, exosomes, and bio-organoids are undertaken, focusing on patient-centric approaches. Services for biopharmaceutical companies and research institutions are provided, ensuring quality and ethical advancements in monoclonal antibodies and diagnostic kits. A future where healthcare is revolutionized is envisioned by Hoynoza, with expertise in plasmid and organoid technologies.

Hoynoza offers Biosimilar Development and Cell and Gene Therapy.

Hoynoza operates through Hoynoza Private Limited.

The legal entities of Hoynoza currently have 4 directors, including Madhava Reddy Gongati, Srinivedha Krishnan, Sathyabalan Murugesan and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available